SITC Archive Library

iSBTc 24th Annual Meeting 

02-26-2018 10:41

The International Society for Biological Therapy of Cancer (iSBTc) 24th Annual Meeting
October 29-31, 2009
Gaylord National Hotel and Convention Center
National Harbor, MD - Washington, DC

Program Organizers
Lieping Chen, MD, PhD - Johns Hopkins University School of Medicine
Robert L. Ferris, MD, PhD, FACS - University of Pittsburgh Cancer Institute
Carl H. June, MD - University of Pennsylvania
Giorgio Trinchieri, MD - National Cancer Institute
Laurence Zitvogel, MD, PhD - Institute Gustave Roussy

Program Summary
The Annual Meeting offers delegates an international forum where immunologic and biologic approaches to cancer treatment are showcased, discussed, and critically evaluated.

Target Audience
The target audience for these programs incorporates basic and clinical investigators from academic, regulatory and biopharmaceutical venues. The audience includes clinicians, researchers, students, post-doctoral fellows and allied health professionals.

Presentations and video recordings are available based on permission from presenters.


#Biomarkers #ClinicalTrials #BrainCancers#ProstateCancer #PresentationSlides #AnnualMeeting #Cytokines #ImmuneCheckpointInhibitors #TherapeuticAntibodies #Vaccines #AlliedHealth #Clinician #Industry #Oncologist #Researcher #2009 #BladderCancer #BreastCancers #CervicalCancer
#ColonCancer #ColorectalCancer #Leukemia #Lymphoma  #Melanoma #RenalCellCarcinoma #AdoptiveCellTherapy
 #CombinationTherapy #Ipilimumab #AdverseEvents #Toxicities

Statistics
0 Favorited
17 Views
32 Files
0 Shares
54 Downloads
Attachment(s)
pdf file
The Biology and Therapy of Brain Metastasis   2.27 MB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Presentation: The Biology and Therapy of Brain Metastasis; Presenter: Isaiah J. Fidler, DVM, PhD - MD Anderson Cancer Center; Date: Thursday, October 29, 2009
pdf file
Identification of Colon Cancer Associated Antigens which ...   164 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Presentation: Identification of Colon Cancer Associated Antigens which would be Key Therapeutic Targets in the Prevention of Disease Relapse or Progression; Presenter: Elizabeth K. Broussard, MD - University of Washington, Tumor Vaccine Group; Date: Thursday, October 29, 2009
pdf file
Identification of Novel CD8+CD57+ T Cell Subset in Human ...   214 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Presentation: Identification of Novel CD8+CD57+ T Cell Subset in Human Melanoma Exhibiting an Incompletely Differentiated CTL Phenotype; Presenter: Richard Wu, BS - MD Anderson Cancer Center; Date: Thursday, October 29, 2009
pdf file
A Data Analysis Method for Identifying Autoantibody Bioma...   422 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Presentation: A Data Analysis Method for Identifying Autoantibody Biomarkers in Cancer Patients Following Immunotherapy; Presenter: Janet Siebert, MS - CytoAnalytics; Date: Thursday, October 29, 2009
pdf file
T Cells-Agents of Tissue and Tumor Immune Surveillance   2.02 MB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Presentation: T Cells-Agents of Tissue and Tumor Immune Surveillance; Presenter: Adrian Hayday, PhD - King's College London; Date: Thursday, October 29, 2009
pdf file
Development of Recombinant Vaccines for the Therapy of Ca...   447 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Presentation: Development of Recombinant Vaccines for the Therapy of Carcinomas; Presenter: Jeffrey Schlom, PhD - National Cancer Institute; Date: Thursday, October 29, 2009
pdf file
Defining the Role of TKIs in Reducing Immune Suppression ...   557 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Presentation: Defining the Role of TKIs in Reducing Immune Suppression While Improving T Cell Responsiveness and Efficacy of Immunotherapy for the Treatment of Tumors; Presenter: James H. Finke, PhD - Cleveland Clinic Foundation; Date: Thursday, October 29, 2009
pdf file
Type-1 Dendritic Cell Vaccines in Combination with Poly-I...   475 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Presentation: Type-1 Dendritic Cell Vaccines in Combination with Poly-ICLC-Associated Between Positive Tetramer Response and 6-Month Progression-Free Survival; Presenter: Hideho Okada, MD, PhD - University of Pittsburgh Cancer Institute; Date: Thursday, October 29, 2009
pdf file
IL-17 Secreting CD8 T Cells - Functional Plasticity and P...   710 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Presentation: IL-17 Secreting CD8 T Cells - Functional Plasticity and Potential Role in Tumor Immunity; Presenter: Charles G. Drake, MD, PhD - Johns Hopkins University; Date: Thursday, October 29, 2009
pdf file
Interleukin-1 Role in Human Th17 responses, Dendritic Cel...   2.74 MB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Presentation: Interleukin-1 Role in Human Th17 responses, Dendritic Cell Activation, and Epithelial Cell Transformation; Presenter: Giorgio Trinchieri, MD - National Cancer Institute; Date: Thursday, October 29, 2009
pdf file
Fc-gamma-R Mediated Regulation of Adaptive Immunity - Imp...   206 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Presentation: Fc-gamma-R Mediated Regulation of Adaptive Immunity - Implications for Antibody Therapies; Presenter: Madhav Dhodapkar, MD - Yale University; Date: Thursday, October 29, 2009
pdf file
Stress-Induced Signals Promote T Cell-Tumor Cell Interact...   339 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Presentation: Stress-Induced Signals Promote T Cell-Tumor Cell Interactions Following Anti-CTLA 4 Therapy; Presenter: Maria Grazia Ruocco, PhD - NYU-School of Medicine, Skirball Institute; Date: Thursday, October 29, 2009
pdf file
Current and Future Preventive HPV Vaccines   134 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Presentation: Current and Future Preventive HPV Vaccines; Presenter: Douglas R. Lowy, MD - National Cancer Institute, Center for Cancer Research; Date: Friday, October 30, 2009
pdf file
Therapeutic Strategies for Human Papillomavirus-Associate...   712 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Presentation: Therapeutic Strategies for Human Papillomavirus-Associated with Cancers; Presenter: Karl Münger, PhD - Brigham & Women's Hospital, Harvard Medical School; Date: Friday, October 30, 2009
pdf file
Definition of the Immunological Properties of Cancer Stem...   941 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Presentation: Definition of the Immunological Properties of Cancer Stem Cells Isolated from Human Glioblastoma; Presenter: Cristina Maccalli, PhD - San Raffaele Foundation Scientific Institute; Date: Friday, October 30, 2009
pdf file
T Cell Delivery of Interleukin-12 to the Tumor Microenvir...   670 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Presentation: T Cell Delivery of Interleukin-12 to the Tumor Microenviroment Triggers Potent Endogenous Anti-Tumor Responses; Presenter: Sid Kerkar, MD - National Cancer institute, Center for Cancer Research; Date: Friday, October 30, 2009
pdf file
Cellular and Molecular Requirements for Rejection of B16 ...   517 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Presentation: Cellular and Molecular Requirements for Rejection of B16 Melanoma in the Setting of Regulatory T Cell Depletion and Homeostatic Proliferation; Presenter: Justin P. Kline, MD - University of Chicago; Date: Friday, October 30, 2009
pdf file
Eradication of Established CD19-Positive Leukemia Using S...   220 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Presentation: Eradication of Established CD19-Positive Leukemia Using Single Injection of Chimeric Immunoreceptor Modified Lentiviral Transduced T Cells in a Xenograph Nog Mouse Model; Presenter: David M. Barrett, MD, PhD - Children's Hospital of Philadelphia; Date: Friday, October 30, 2009
pdf file
Checkpoint Blockade in Tumor Immunotherapy - New Insights...   2.08 MB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Presentation: Checkpoint Blockade in Tumor Immunotherapy - New Insights and Opportunities; Presenter: James P. Allison, PhD - Memorial Sloan-Kettering Cancer Center; Date: Friday, October 30, 2009
pdf file
Manipulation of the Tumor Microenvironment by CTLA-4 Bloc...   197 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Presentation: Manipulation of the Tumor Microenvironment by CTLA-4 Blockade; Presenter: Padmanee Sharma, MD, PhD - MD Anderson Cancer Center; Date: Friday, October 30, 2009
pdf file
Eosinophilic Granulocytes Modulate Tumor Microenvironment...   582 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Presentation: Eosinophilic Granulocytes Modulate Tumor Microenvironment by Oxidizing Damage Associated Molecular Pattern Molecules Derived From Necrotic Tumor Cells; Presenter: Ramin Lotfi, MD - University of Ulm, Institute for Transfusion Medicine; Date: Friday, October 30, 2009
pdf file
Small-Molecule Inhibitors of the IDO Pathway as Immune Mo...   859 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Presentation: Small-Molecule Inhibitors of the IDO Pathway as Immune Modulators; Presenter: David H. Munn, MD - Medical College of Georgia; Date: Friday, October 30, 2009
pdf file
Small Molecule Currcumin Analogs Induce Apoptosis in Huma...   375 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Presentation: Small Molecule Currcumin Analogs Induce Apoptosis in Human Melanoma Cells via STAT3 Inhibition but do not Alter the Cellular Response to Immunotherapeutic Cytokines; Presenter: Gregory B. Lesinski, PhD - The Ohio State University Comprehensive Cancer Center; Date: Friday, October 30, 2009
pdf file
2008 Workshop on Cancer and Inflammation Update - Promise...   1.08 MB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Presentation: 2008 Workshop on Cancer and Inflammation Update - Promise for Biological Therapy; Presenter: Micahel T. Lotze, MD - University of Pittsburgh Cancer Institute; Date: Friday, October 30, 2009
pdf file
Development of Cellular Immunology   3.07 MB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Presentation: Development of Cellular Immunology; Presenter: Steven A. Rosenberg, MD, PhD - National Cancer Institute; Date: Saturday, October 31, 2009
pdf file
What are the Functional and Phenotypic Qualities of Thera...   2.31 MB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Presentation: What are the Functional and Phenotypic Qualities of Therapeutically Successful Anti-Tumor T Cells; Presenter: Nicholas P. Restifo, Md - National Cancer Instutite; Date: Saturday, October 31, 2009
pdf file
Programming Tumor-Reactive Effector Memory CD8+ T Cells i...   480 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Presentation: Programming Tumor-Reactive Effector Memory CD8+ T Cells in Vitro Obivates the Requirement for in Vivo Vaccination; Presenter: Christopher A. Klebanoff, MD - National Institutes of Health, Center for Cancer Research; Date: Saturday, October 31, 2009
pdf file
Adoptive Transfer of T Cells Genetically Modified Using t...   1.32 MB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Presentation: Adoptive Transfer of T Cells Genetically Modified Using the Sleeping Beauty System; Presenter: Laurence J.N. Cooper, MD - MD Anderson Cancer Center; Date: Saturday, October 31, 2009
pdf file
209.217 (210M) Peptide Followed by High Dose IL-2 vs High Dose IL-2 along in Patients with Metastatic Melanoma   190 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Presentation: A Phase III Multi-Institutional Randomized Study of Immunization with the pg100:209.217 (210M) Peptide Followed by High Dose IL-2 vs High Dose IL-2 along in Patients with Metastatic Melanoma; Presenter: Doug J. Schwartzentruber, MD, FACS - Goshen Center for Cancer Care; Date: Saturday, October 31, 2009
pdf file
Progress of an Active Immunotherapy for Prostate Cancer   244 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Session: Hot Topic Symposium - Positive Immunotherapy Clinical Trial Outcomes; Presentation: Development History of Sipuleucel-T: Progress of an Active Immunotherapy for Prostate Cancer; Presenter: David L. Urdal, PhD - Dendreon Corporation; Date: Saturday, October 31, 2009
pdf file
NY-ESO-1 Specific Responses in Patients with Advanced Pro...   548 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Session: Hot Topic Symposium - Positive Immunotherapy Clinical Trial Outcomes; Presentation: NY-ESO-1 Specific Responses in Patients with Advanced Prostate Cancer Treated with Ipilimumab; Presenter: Jianda Yuan, MD, PhD - Memorial Sloan-Kettering Cancer Center; Date: Saturday, October 31, 2009
pdf file
Circulating Regulatory T Cell Function and Overall Surviv...   452 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 24th Annual Meeting; Session: Hot Topic Symposium - Positive Immunotherapy Clinical Trial Outcomes; Presentation: Circulating Regulatory T Cell Function and Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Poxviral-Based Vaccine; Presenter: Matteo Vergati, MD - National Cancer Institute, Center for Cancer Research; Date: Saturday, October 31, 2009